Study to Evaluate the Safety of Nanoxel M Inj.

Conditions

• Breast Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Ovarian Cancer
• Head and Neck Cancer
• Gastric Cancer
• Esophageal Cancer

Sponsor

Samyang Biopharmaceuticals Corporation